214-OR: Cambridge Hybrid Closed-Loop in Children and Adolescents with T1D: A Multicentre Six-Month Randomised Trial

Aims: We assessed safety and efficacy of Cambridge hybrid closed-loop (HCL) compared with usual care over 6 months in children and young people with T1D. Methods: In an open-label multicentre multinational parallel randomised controlled trial, we randomly assigned participants on insulin pump therap...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2021-06, Vol.70 (Supplement_1)
Hauptverfasser:	FUCHS, JULIA, BOUGHTON, CHARLOTTE K., ALLEN, JANET M., WILINSKA, MALGORZATA E., TAUSCHMANN, MARTIN, DENVIR, LOUISE, THANKAMONY, AJAY, CAMPBELL, FIONA, WADWA, R. PAUL, BUCKINGHAM, BRUCE A., DAVIS, NIKKI, DIMEGLIO, LINDA, MAURAS, NELLY, BESSER, RACHEL, GHATAK, ATRAYEE, WEINZIMER, STUART A., HOOD, KOREY K., FOX, D. STEVEN, KANAPKA, LAUREN, KOLLMAN, CRAIG, SIBAYAN, JUDY, BECK, ROY, HOVORKA, ROMAN
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescents Adverse events Children Childrens health Clinical trials Closed loop systems Control algorithms Diabetes Diabetes mellitus (insulin dependent) Drug delivery systems Hypoglycemia Insulin Pediatrics Side effects Teenagers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!